| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T51 |
0-137 |
Sentence |
denotes |
Table 1 Systematic representation of the clinical trials of COVID19 and MSC or their derivatives registered with NIH, USA till 23.05.2020 |
| T52 |
138-143 |
Sentence |
denotes |
S.No. |
| T53 |
144-309 |
Sentence |
denotes |
Clinical trial number Study Title Phase Status Sample Size(n) CellularInterventions Date of Start (DOS)Date of Completion (DOC) Gender(Male/Female/ Both) Age Country |
| T54 |
310-442 |
Sentence |
denotes |
1- NCT04315987 Nest Cell ®Mesenchymal Stem Cell to Treat Patients with Severe COVID19 Pneumonia I Not Recruiting 66 Nest Cell ® DOS: |
| T55 |
443-453 |
Sentence |
denotes |
April 2020 |
| T56 |
454-458 |
Sentence |
denotes |
DOC: |
| T57 |
459-498 |
Sentence |
denotes |
June 2020 Both 18 Yrs. and older Brazil |
| T58 |
499-617 |
Sentence |
denotes |
2- NCT04313322 Treatment of COVID19 Patients Using Wharton’s Jelly- Mesenchymal Stem Cells I Recruiting 5 WJ-MSCs DOS: |
| T59 |
618-628 |
Sentence |
denotes |
March 2020 |
| T60 |
629-677 |
Sentence |
denotes |
DOC:September 2020 Both 18 Yrs. and older Jordan |
| T61 |
678-805 |
Sentence |
denotes |
3- NCT04288102 Treatment With Mesenchymal Stem Cells for Severe Corona Virus Diseases 2019 (COVID19) II Recruiting 90 MSCs DOS: |
| T62 |
806-816 |
Sentence |
denotes |
March 2020 |
| T63 |
817-821 |
Sentence |
denotes |
DOC: |
| T64 |
822-849 |
Sentence |
denotes |
July 2020 Both 18 to75 Yrs. |
| T65 |
850-855 |
Sentence |
denotes |
China |
| T66 |
856-1001 |
Sentence |
denotes |
4- NCT04302519 Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells Early phaseI Not Recruiting 24 DPSCs DOS: |
| T67 |
1002-1012 |
Sentence |
denotes |
March 2020 |
| T68 |
1013-1017 |
Sentence |
denotes |
DOC: |
| T69 |
1018-1047 |
Sentence |
denotes |
July 2021 Both 18 to75 Yrs. – |
| T70 |
1048-1180 |
Sentence |
denotes |
5- NCT04252118 Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With 2019 Novel Coronavirus I Recruiting 20 MSCs DOS: |
| T71 |
1181-1193 |
Sentence |
denotes |
January 2020 |
| T72 |
1194-1198 |
Sentence |
denotes |
DOC: |
| T73 |
1199-1230 |
Sentence |
denotes |
December 2021 Both 18 to70 Yrs. |
| T74 |
1231-1236 |
Sentence |
denotes |
China |
| T75 |
1237-1392 |
Sentence |
denotes |
6- NCT04273646 Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Novel Coronavirus Severe Pneumonia – Not Recruiting 48 UC-MSCs DOS: |
| T76 |
1393-1403 |
Sentence |
denotes |
April 2020 |
| T77 |
1404-1408 |
Sentence |
denotes |
DOC: |
| T78 |
1409-1441 |
Sentence |
denotes |
February 2022 Both 18 to 65 Yrs. |
| T79 |
1442-1447 |
Sentence |
denotes |
China |
| T80 |
1448-1628 |
Sentence |
denotes |
7- NCT04276987 A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia I Not Recruiting 30 Exosomes derived from AD-MSCs |
| T81 |
1629-1644 |
Sentence |
denotes |
(MSCs-Exo) DOS: |
| T82 |
1645-1658 |
Sentence |
denotes |
February 2020 |
| T83 |
1659-1663 |
Sentence |
denotes |
DOC: |
| T84 |
1664-1693 |
Sentence |
denotes |
July 2020 Both 18 to75 Yrs. – |
| T85 |
1694-1703 |
Sentence |
denotes |
8- NCT043 |
| T86 |
1704-1730 |
Sentence |
denotes |
36,254 Safety and Efficacy |
| T87 |
1731-1750 |
Sentence |
denotes |
Study of Allogeneic |
| T88 |
1751-1768 |
Sentence |
denotes |
Human Dental Pulp |
| T89 |
1769-1785 |
Sentence |
denotes |
Mesenchymal Stem |
| T90 |
1786-1807 |
Sentence |
denotes |
Cells to Treat Severe |
| T91 |
1808-1858 |
Sentence |
denotes |
COVID19 Patients I and II Recruiting 20 DPSCs DOS: |
| T92 |
1859-1869 |
Sentence |
denotes |
April 2020 |
| T93 |
1870-1874 |
Sentence |
denotes |
DOC: |
| T94 |
1875-1880 |
Sentence |
denotes |
March |
| T95 |
1881-1904 |
Sentence |
denotes |
2021 Both 18 to 65 Yrs. |
| T96 |
1905-1910 |
Sentence |
denotes |
China |
| T97 |
1911-1920 |
Sentence |
denotes |
9- NCT043 |
| T98 |
1921-1966 |
Sentence |
denotes |
39,660 Clinical Research of Human Mesenchymal |
| T99 |
1967-2051 |
Sentence |
denotes |
Stem Cells in the Treatment of COVID19 Pneumonia I and II Recruiting 30 UC-MSCs DOS: |
| T100 |
2052-2065 |
Sentence |
denotes |
February 2020 |
| T101 |
2066-2070 |
Sentence |
denotes |
DOC: |
| T102 |
2071-2099 |
Sentence |
denotes |
June 2020 Both 18 to 75 Yrs. |
| T103 |
2100-2105 |
Sentence |
denotes |
China |
| T104 |
2106-2116 |
Sentence |
denotes |
10- NCT043 |
| T105 |
2117-2143 |
Sentence |
denotes |
46,368 Bone Marrow-Derived |
| T106 |
2144-2160 |
Sentence |
denotes |
Mesenchymal Stem |
| T107 |
2161-2179 |
Sentence |
denotes |
Cell Treatment for |
| T108 |
2180-2200 |
Sentence |
denotes |
Severe Patients With |
| T109 |
2201-2220 |
Sentence |
denotes |
Coronavirus Disease |
| T110 |
2221-2248 |
Sentence |
denotes |
2019 (COVID19) I and II Not |
| T111 |
2249-2275 |
Sentence |
denotes |
Recruiting 20 BM-MSCs DOS: |
| T112 |
2276-2286 |
Sentence |
denotes |
April 2020 |
| T113 |
2287-2291 |
Sentence |
denotes |
DOC: |
| T114 |
2292-2300 |
Sentence |
denotes |
December |
| T115 |
2301-2324 |
Sentence |
denotes |
2020 Both 18 to 75 Yrs. |
| T116 |
2325-2330 |
Sentence |
denotes |
China |
| T117 |
2331-2341 |
Sentence |
denotes |
11- NCT043 |
| T118 |
2342-2368 |
Sentence |
denotes |
52,803 Adipose Mesenchymal |
| T119 |
2369-2391 |
Sentence |
denotes |
Cells for Abatement of |
| T120 |
2392-2402 |
Sentence |
denotes |
SARS CoV-2 |
| T121 |
2403-2414 |
Sentence |
denotes |
Respiratory |
| T122 |
2415-2428 |
Sentence |
denotes |
Compromise in |
| T123 |
2429-2478 |
Sentence |
denotes |
COVID-19 Disease I Not Recruiting 20 AD-MSCs DOS: |
| T124 |
2479-2489 |
Sentence |
denotes |
April 2020 |
| T125 |
2490-2494 |
Sentence |
denotes |
DOC: |
| T126 |
2495-2526 |
Sentence |
denotes |
April 2026 Both 18 to 90 Yrs. – |
| T127 |
2527-2537 |
Sentence |
denotes |
12- NCT043 |
| T128 |
2538-2564 |
Sentence |
denotes |
49,631 A Clinical Trial to |
| T129 |
2565-2585 |
Sentence |
denotes |
Determine the Safety |
| T130 |
2586-2606 |
Sentence |
denotes |
and Efficacy of Hope |
| T131 |
2607-2618 |
Sentence |
denotes |
Biosciences |
| T132 |
2619-2629 |
Sentence |
denotes |
Autologous |
| T133 |
2630-2646 |
Sentence |
denotes |
Mesenchymal Stem |
| T134 |
2647-2670 |
Sentence |
denotes |
Cell Therapy (HBadMSCs) |
| T135 |
2671-2681 |
Sentence |
denotes |
to Provide |
| T136 |
2682-2700 |
Sentence |
denotes |
Protection Against |
| T137 |
2701-2724 |
Sentence |
denotes |
COVID19 II Enrolling by |
| T138 |
2725-2751 |
Sentence |
denotes |
invitation 56 AD-MSCs DOS: |
| T139 |
2752-2760 |
Sentence |
denotes |
May 2020 |
| T140 |
2761-2765 |
Sentence |
denotes |
DOC: |
| T141 |
2766-2798 |
Sentence |
denotes |
December 2020 Both Child, Adult, |
| T142 |
2799-2804 |
Sentence |
denotes |
Older |
| T143 |
2805-2824 |
Sentence |
denotes |
Adult United States |
| T144 |
2825-2835 |
Sentence |
denotes |
13- NCT030 |
| T145 |
2836-2858 |
Sentence |
denotes |
42,143 Repair of Acute |
| T146 |
2859-2879 |
Sentence |
denotes |
Respiratory Distress |
| T147 |
2880-2899 |
Sentence |
denotes |
Syndrome by Stromal |
| T148 |
2900-2919 |
Sentence |
denotes |
Cell Administration |
| T149 |
2920-2939 |
Sentence |
denotes |
(REALIST) (COVID19) |
| T150 |
2940-3008 |
Sentence |
denotes |
(REALIST) I and II Recruiting 75 UC derived CD362 enriched MSCs DOS: |
| T151 |
3009-3021 |
Sentence |
denotes |
January 2019 |
| T152 |
3022-3026 |
Sentence |
denotes |
DOC: |
| T153 |
3027-3077 |
Sentence |
denotes |
October 2022 Both 16 Yrs. and older United Kingdom |
| T154 |
3078-3088 |
Sentence |
denotes |
14- NCT043 |
| T155 |
3089-3140 |
Sentence |
denotes |
90,152 Safety and Efficacy of Intravenous Wharton’s |
| T156 |
3141-3154 |
Sentence |
denotes |
Jelly Derived |
| T157 |
3155-3171 |
Sentence |
denotes |
Mesenchymal Stem |
| T158 |
3172-3186 |
Sentence |
denotes |
Cells in Acute |
| T159 |
3187-3207 |
Sentence |
denotes |
Respiratory Distress |
| T160 |
3208-3271 |
Sentence |
denotes |
Syndrome due to COVID19 I and II Not Recruiting 40 WJ-MSCs DOS: |
| T161 |
3272-3281 |
Sentence |
denotes |
June 2020 |
| T162 |
3282-3286 |
Sentence |
denotes |
DOC: |
| T163 |
3287-3314 |
Sentence |
denotes |
May 2021 Both 18 to 80 Yrs. |
| T164 |
3315-3323 |
Sentence |
denotes |
Colombia |
| T165 |
3324-3334 |
Sentence |
denotes |
15- NCT043 |
| T166 |
3335-3354 |
Sentence |
denotes |
82,547 Treatment of |
| T167 |
3355-3373 |
Sentence |
denotes |
COVID19 Associated |
| T168 |
3374-3388 |
Sentence |
denotes |
Pneumonia with |
| T169 |
3389-3405 |
Sentence |
denotes |
Allogenic Pooled |
| T170 |
3406-3429 |
Sentence |
denotes |
Olfactory Mucosaderived |
| T171 |
3430-3441 |
Sentence |
denotes |
Mesenchymal |
| T172 |
3442-3492 |
Sentence |
denotes |
Stem Cells I and II Not Recruiting 40 OM-MSCs DOS: |
| T173 |
3493-3501 |
Sentence |
denotes |
May 2020 |
| T174 |
3502-3506 |
Sentence |
denotes |
DOC: |
| T175 |
3507-3534 |
Sentence |
denotes |
June 2021 Both 18 to70 Yrs. |
| T176 |
3535-3542 |
Sentence |
denotes |
Belarus |
| T177 |
3543-3553 |
Sentence |
denotes |
16- NCT043 |
| T178 |
3554-3585 |
Sentence |
denotes |
66,323 Clinical Trial to Assess |
| T179 |
3586-3600 |
Sentence |
denotes |
the Safety and |
| T180 |
3601-3624 |
Sentence |
denotes |
Efficacy of Intravenous |
| T181 |
3625-3659 |
Sentence |
denotes |
Administration of Allogeneic Adult |
| T182 |
3660-3676 |
Sentence |
denotes |
Mesenchymal Stem |
| T183 |
3677-3694 |
Sentence |
denotes |
Cells of Expanded |
| T184 |
3695-3798 |
Sentence |
denotes |
Adipose Tissue in Patients with Severe Pneumonia due to COVID19 I and II Not Recruiting 26 AD-MSCs DOS: |
| T185 |
3799-3809 |
Sentence |
denotes |
April 2020 |
| T186 |
3810-3814 |
Sentence |
denotes |
DOC: |
| T187 |
3815-3848 |
Sentence |
denotes |
October 2021 Both 18 to 80 Yrs. – |
| T188 |
3849-3859 |
Sentence |
denotes |
17- NCT043 |
| T189 |
3860-3883 |
Sentence |
denotes |
66,063 Mesenchymal Stem |
| T190 |
3884-3919 |
Sentence |
denotes |
Cell Therapy for SARS-CoV-2-related |
| T191 |
3920-3937 |
Sentence |
denotes |
Acute Respiratory |
| T192 |
3938-4033 |
Sentence |
denotes |
Distress Syndrome II and III Recruiting 60 MSCs, and Exosomes derived from MSCs (MSCs-Exo) DOS: |
| T193 |
4034-4044 |
Sentence |
denotes |
April 2020 |
| T194 |
4045-4049 |
Sentence |
denotes |
DOC: |
| T195 |
4050-4082 |
Sentence |
denotes |
December 2020 Both 18 to 65 Yrs. |
| T196 |
4083-4087 |
Sentence |
denotes |
Iran |
| T197 |
4088-4098 |
Sentence |
denotes |
18- NCT043 |
| T198 |
4099-4122 |
Sentence |
denotes |
77,334 Mesenchymal Stem |
| T199 |
4123-4152 |
Sentence |
denotes |
Cells (MSCs) in Inflammation- |
| T200 |
4153-4172 |
Sentence |
denotes |
Resolution Programs |
| T201 |
4173-4187 |
Sentence |
denotes |
of Coronavirus |
| T202 |
4188-4200 |
Sentence |
denotes |
Disease 2019 |
| T203 |
4201-4218 |
Sentence |
denotes |
(COVID19) Induced |
| T204 |
4219-4236 |
Sentence |
denotes |
Acute Respiratory |
| T205 |
4237-4254 |
Sentence |
denotes |
Distress Syndrome |
| T206 |
4255-4295 |
Sentence |
denotes |
(ARDS) II Not Recruiting 40 BM-MSCs DOS: |
| T207 |
4296-4304 |
Sentence |
denotes |
May 2020 |
| T208 |
4305-4309 |
Sentence |
denotes |
DOC: |
| T209 |
4310-4354 |
Sentence |
denotes |
February 2021 Both 18 Yrs. and older Germany |
| T210 |
4355-4365 |
Sentence |
denotes |
19- NCT043 |
| T211 |
4366-4388 |
Sentence |
denotes |
71,393 MSCs in COVID19 |
| T212 |
4389-4417 |
Sentence |
denotes |
ARDS III Recruiting 300 MSCs |
| T213 |
4418-4436 |
Sentence |
denotes |
Remestemcel-L DOS: |
| T214 |
4437-4451 |
Sentence |
denotes |
April 30, 2020 |
| T215 |
4452-4456 |
Sentence |
denotes |
DOC: |
| T216 |
4457-4504 |
Sentence |
denotes |
April 2022 Both 18 Yrs. and older United States |
| T217 |
4505-4515 |
Sentence |
denotes |
20- NCT043 |
| T218 |
4516-4542 |
Sentence |
denotes |
62,189 Efficacy and Safety |
| T219 |
4543-4562 |
Sentence |
denotes |
Study of Allogeneic |
| T220 |
4563-4636 |
Sentence |
denotes |
HB-adMSCs for the Treatment of COVID19 II Not Recruiting 110 AD-MSCs DOS: |
| T221 |
4637-4645 |
Sentence |
denotes |
May 2020 |
| T222 |
4646-4650 |
Sentence |
denotes |
DOC: |
| T223 |
4651-4675 |
Sentence |
denotes |
October 2020 Both Child, |
| T224 |
4676-4682 |
Sentence |
denotes |
Adult, |
| T225 |
4683-4688 |
Sentence |
denotes |
Older |
| T226 |
4689-4708 |
Sentence |
denotes |
Adult United States |
| T227 |
4709-4719 |
Sentence |
denotes |
21- NCT043 |
| T228 |
4720-4744 |
Sentence |
denotes |
66,271 Clinical Trial of |
| T229 |
4745-4755 |
Sentence |
denotes |
Allogeneic |
| T230 |
4756-4773 |
Sentence |
denotes |
Mesenchymal Cells |
| T231 |
4774-4793 |
Sentence |
denotes |
from Umbilical Cord |
| T232 |
4794-4817 |
Sentence |
denotes |
Tissue in Patients with |
| T233 |
4818-4856 |
Sentence |
denotes |
COVID19 II Recruiting 106 UC-MSCs DOS: |
| T234 |
4857-4865 |
Sentence |
denotes |
May 2020 |
| T235 |
4866-4870 |
Sentence |
denotes |
DOC: |
| T236 |
4871-4898 |
Sentence |
denotes |
May 2021 Both 40 to 80 Yrs. |
| T237 |
4899-4904 |
Sentence |
denotes |
Spain |
| T238 |
4905-4915 |
Sentence |
denotes |
22- NCT043 |
| T239 |
4916-4936 |
Sentence |
denotes |
48,435 A Randomized, |
| T240 |
4937-4950 |
Sentence |
denotes |
Double-Blind, |
| T241 |
4951-4969 |
Sentence |
denotes |
Placebo-Controlled |
| T242 |
4970-5029 |
Sentence |
denotes |
Clinical Trial to Determine the Safety and Efficacy of Hope |
| T243 |
5030-5041 |
Sentence |
denotes |
Biosciences |
| T244 |
5042-5052 |
Sentence |
denotes |
Allogeneic |
| T245 |
5053-5069 |
Sentence |
denotes |
Mesenchymal Stem |
| T246 |
5070-5175 |
Sentence |
denotes |
Cell Therapy (HBadMSCs) to Provide Protection Against COVID19 II Enrolling by invitation 100 AD-MSCs DOS: |
| T247 |
5176-5186 |
Sentence |
denotes |
April 2020 |
| T248 |
5187-5191 |
Sentence |
denotes |
DOC: |
| T249 |
5192-5214 |
Sentence |
denotes |
April 2021 Both Child, |
| T250 |
5215-5227 |
Sentence |
denotes |
Adult, Older |
| T251 |
5228-5247 |
Sentence |
denotes |
Adult United States |
| T252 |
5248-5258 |
Sentence |
denotes |
23- NCT043 |
| T253 |
5259-5310 |
Sentence |
denotes |
71,601 Safety and Effectiveness of Mesenchymal Stem |
| T254 |
5311-5426 |
Sentence |
denotes |
Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 Early Phase I Active not Recruiting 60 UC-MSCs DOS: |
| T255 |
5427-5437 |
Sentence |
denotes |
March 2020 |
| T256 |
5438-5442 |
Sentence |
denotes |
DOC: |
| T257 |
5443-5475 |
Sentence |
denotes |
December 2022 Both 18 to 70 Yrs. |
| T258 |
5476-5481 |
Sentence |
denotes |
China |
| T259 |
5482-5492 |
Sentence |
denotes |
24- NCT043 |
| T260 |
5493-5571 |
Sentence |
denotes |
55,728 Use of UC-MSCs for COVID19 Patients I and II Recruiting 24 UC-MSCs DOS: |
| T261 |
5572-5582 |
Sentence |
denotes |
April 2020 |
| T262 |
5583-5587 |
Sentence |
denotes |
DOC: |
| T263 |
5588-5633 |
Sentence |
denotes |
May 2021 Both 18 Yrs. and older United States |
| T264 |
5634-5644 |
Sentence |
denotes |
25- NCT043 |
| T265 |
5645-5672 |
Sentence |
denotes |
92,778 Clinical Use of Stem |
| T266 |
5673-5743 |
Sentence |
denotes |
Cells for the Treatment of COVID19 I and II Recruiting 30 UC-MSCs DOS: |
| T267 |
5744-5754 |
Sentence |
denotes |
April 2020 |
| T268 |
5755-5759 |
Sentence |
denotes |
DOC: |
| T269 |
5760-5793 |
Sentence |
denotes |
September 2020 Both 40 to 60 Yrs. |
| T270 |
5794-5800 |
Sentence |
denotes |
Turkey |
| T271 |
5801-5811 |
Sentence |
denotes |
26- NCT043 |
| T272 |
5812-5981 |
Sentence |
denotes |
97,796 Study of the Safety of Therapeutic Tx with Immunomodulatory MSC in Adults with COVID19 Infection Requiring Mechanical Ventilation I Not Recruiting 45 BM-MSCs DOS: |
| T273 |
5982-5991 |
Sentence |
denotes |
June 2020 |
| T274 |
5992-5996 |
Sentence |
denotes |
DOC: |
| T275 |
5997-6027 |
Sentence |
denotes |
June 2021 Both 18 to 80 Yrs. – |
| T276 |
6028-6038 |
Sentence |
denotes |
27- NCT043 |
| T277 |
6039-6065 |
Sentence |
denotes |
90,139 Efficacy and Safety |
| T278 |
6066-6096 |
Sentence |
denotes |
Evaluation of Mesenchymal Stem |
| T279 |
6097-6132 |
Sentence |
denotes |
Cells for the Treatment of Patients |
| T280 |
6133-6149 |
Sentence |
denotes |
with Respiratory |
| T281 |
6150-6205 |
Sentence |
denotes |
Distress to COVID19 I and II Recruiting 30 WJ-MSCs DOS: |
| T282 |
6206-6214 |
Sentence |
denotes |
May 2020 |
| T283 |
6215-6219 |
Sentence |
denotes |
DOC: |
| T284 |
6220-6252 |
Sentence |
denotes |
December 2020 Both 18 to 75 Yrs. |
| T285 |
6253-6258 |
Sentence |
denotes |
Spain |
| T286 |
6259-6269 |
Sentence |
denotes |
28- NCT042 |
| T287 |
6270-6317 |
Sentence |
denotes |
69,525 Umbilical Cord (UC)- Derived Mesenchymal |
| T288 |
6318-6335 |
Sentence |
denotes |
Stem Cells (MSCs) |
| T289 |
6336-6423 |
Sentence |
denotes |
Treatment for the 2019-novel Coronavirus (nCOV) Pneumonia II Recruiting 10 UC-MSCs DOS: |
| T290 |
6424-6437 |
Sentence |
denotes |
February 2020 |
| T291 |
6438-6442 |
Sentence |
denotes |
DOC: |
| T292 |
6443-6476 |
Sentence |
denotes |
September 2020 Both 18 to 75 Yrs. |
| T293 |
6477-6482 |
Sentence |
denotes |
China |
